← Eichor
Study identifier: NCT06715306 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Intravenous Versus Oral Treatment of the Main Acute Infections

Condition: Respiratory Tract Infections · Urinary Tract Infections · Cellulitis  ·  Sponsor: University of Southern Denmark

PhaseNA
Planned participants4000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Patients admitted to the hospital with acute infections are often treated with intravenous (IV) antibiotics. Around 70% of these infections fall into three categories: respiratory tract infections, urinary tract infections, and cellulitis. A Danish study found that 76% of patients admitted with suspected community-acquired pneumonia and treated with antibiotics received them intravenously. Based on an extrapolated estimate from an unpublished local survey, approximately 50,000 patients in Denmark are admitted each year for infections and treated with IV antibiotics. The average hospital stay for these patients is 5.9 days, resulting in a total of 295,000 hospital days annually, accounting for about 7% of total hospital admissions in Denmark. This represents an annual cost of 2.3 billion DKK. While some patients need hospitalization due to their overall health or other serious conditions, others remain hospitalized primarily to receive IV antibiotics. Expanding the use of oral antibiotics in emergency departments should be pursued only if it can demonstrate comparable efficacy and safety to IV administration. Therefore this study will investigate the efficiency of primarily oral antibiotics in acutely admitted patients with proven or suspected infections. Additionally, the investigators will evaluate the safety of oral regimen for these patients.

This description comes directly from the study's public registry record.

Talk to the study team

Mariana Bichuette Cartuliares  ·  +45 79971113  ·  mbc@rsyd.dk

Helene Skjøt-Arkil  ·  +45 79971113  ·  hsa@rsyd.dk

Always discuss trial participation with your own doctor first.

Locations (7)

Sygehus SønderjyllandAabenraa, Southern Denmark, DenmarkRecruiting
Bispebjerg and Frederiksberg HospitalCopenhagen, DenmarkActive Not Recruiting
Nordsjællands HospitalCopenhagen, DenmarkRecruiting
Esbjerg and Grindsted SygehusEsbjerg, DenmarkRecruiting
Herlev and Gentofte HospitalHerlev, DenmarkActive Not Recruiting
Amager and Hvidovre HospitalHvidovre, DenmarkActive Not Recruiting
Sygehus LillebæltKolding, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06715306